The long-term prognostic value of survivin expressing circulating tumor cells in patients with high-risk non-muscle invasive bladder cancer (NMIBC)
Chiara Nicolazzo(Sapienza University of Rome), Cristina Raimondi(Sapienza University of Rome), Paola Gazzaniga(Sapienza University of Rome), Gian Maria Busetto(Sapienza University of Rome), Isabella Sperduti(San Gallicano Hospital), Angela Gradilone(Sapienza University of Rome), Diana Giannarelli(Agostino Gemelli University Polyclinic), Francesco Del Giudice(Sapienza University of Rome), Ettore De Berardinis(Policlinico Umberto I)
Cited by 44
Related Papers
Male Oxidative Stress Infertility (MOSI): Proposed Terminology and Clinical Practice Guidelines for Management of Idiopathic Male Infertility
|The World Journal of Men s Health|2019|468
The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper
|Critical Reviews in Oncology/Hematology|2018|268
Prospective Assessment of Vesical Imaging Reporting and Data System (VI-RADS) and Its Clinical Impact on the Management of High-risk Non–muscle-invasive Bladder Cancer Patients Candidate for Repeated Transurethral Resection
|European Urology|2019|212